New Zealand markets open in 4 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
820.85-2.47 (-0.30%)
As of 03:56PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close823.32
Bid821.31 x 800
Ask822.63 x 1000
Day's range809.24 - 823.08
52-week range668.00 - 853.97
Avg. volume451,079
Market cap89.429B
Beta (5Y monthly)0.14
PE ratio (TTM)23.40
EPS (TTM)35.08
Earnings date01 Feb 2024 - 05 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est920.09
  • Zacks

    EyePoint (EYPT) Surges 178% on Upbeat Phase II Eye Disease Data

    EyePoint (EYPT) announces positive top-line data from the phase II study of its investigational candidate, EYP-1901, in the treatment of wet age-related macular degeneration. The stock rallies 178%.

  • Insider Monkey

    JP Morgan’s Top 15 Stock Picks for 2023 and Now

    In this piece, we will take a look at JP Morgan’s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world’s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan’s Top 5 Stock Picks for 2023. […]

  • GlobeNewswire

    Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio

    TARRYTOWN, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous webcast to provide an update on the company's hematology portfolio on Thursday, December 14, 2023 at 8:30 AM ET. This investor call follows Regeneron data updates presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, from December 9-12, 2023. The webcast may be accessed from the "Investors & Media" page of Regeneron's w